MGVS clinical research program is focused on areas of unmet needs in cardiovascular disease.
MGVS is committed to transparency in medical research. We have registered our active company-sponsored clinical trials on the National Institutes of Health clinical trial database.
www.clinicaltrials.gov

MultiGeneAngio
We have recently completed enrollment and treatment of 12 patients in the first phase I/IIa study of MultiGeneAngio for severe claudication in two leading medical centers in the USA, the University of Michigan and  the University of Pennsylvania. Preliminary assessment demonstrated promising safety and clinical results. A second clinical study for critical limb ischemia, which is a more advanced stage of peripheral arterial disease, is planned for Q1 of 2010 in 5 leading medical centers in Israel:

Barzilai Medical Center, Ashkelon
PI: Prof. Boris Yoffe, M.D.
Tel: 972-8-6745656
Email: sarel@barzi.health.gov.il

Chaim Sheba Medical Center , Tel-Hashomer
PI: Dr. Moshe Halak
Tel: 972-3-5302712
Email: Moshe.Halak@sheba.health.gov.il

Hadassah University Hospital, Ein Kerem, Jerusalem
PI: Dr. Chen Rubinstein
Tel: 972-2-6776958
Email: chen.anat@gmail.com

Kaplan Medical Center, Rehovot
PI: Dr. Eran Weinmann
Tel: 972-8-9441761
Email: eew@clalit.org.il

Rambam Medical Center, Haifa
PI: Prof. Aaron Hoffman
Tel: 972-4-8543119, 972-4-8541299
Email: ahofman@rambam.health.gov.il